Eisler Capital Management’s Idexx Laboratories IDXX Stock Holding History

Eisler Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$204K	Buy	+320	New	+$194K	﹤0.01%	758

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Eisler Capital Management's IDXX Position: Q3 2025 in Review

Eisler Capital Management opened a new position in Idexx Laboratories (IDXX) in Q3 2025: 320 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #758 among its holdings.

1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

Eisler Capital Management held 320 shares of Idexx Laboratories worth $204K as of Q3 2025.
Idexx Laboratories was a new Eisler Capital Management position in Q3 2025.
Idexx Laboratories made up ﹤0.01% of Eisler Capital Management's portfolio in Q3 2025, its #758 holding.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.